Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin
- PMID: 4263497
- PMCID: PMC292433
- DOI: 10.1172/JCI107107
Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin
Abstract
Fibrin formed in response to ancrod, reptilase, or thrombin was reduced by beta-mercaptoethanol and examined by sodium dodecyl sulfate polyacrylamide gel electrophoresis. It was found that ancrod progressively and totally digested the alpha-chains of fibrin monomers at sites different than plasmin; however, further digestion of fibrin monomers by either reptilase or thrombin was not observed. Highly purified ancrod did not activate fibrin-stabilizing factor (FSF); however, the reptilase preparation used in these experiments, like thrombin, activated FSF and thereby promoted cross-link formation. Fibrin, formed by clotting purified human fibrinogen with ancrod, reptilase, or thrombin for increasing periods of time in the presence of plasminogen, was incubated with urokinase and observed for complete lysis. Fibrin formed by ancrod was strikingly more vulnerable to plasmin digestion than was fibrin formed by reptilase or thrombin. The lysis times for fibrin formed for 2 hr by ancrod, reptilase, or thrombin were 18, 89, and 120 min, respectively. Evidence was also obtained that neither ancrod nor reptilase activated human plasminogen. These results indicate that fibrin formed by ancrod is not cross-linked and has significantly degraded alpha-chains: as expected, ancrod-formed fibrin is markedly susceptible to digestion by plasmin.
Similar articles
-
The fibrinogenolytic activity of purified tryptase from human lung mast cells.J Immunol. 1985 Oct;135(4):2762-7. J Immunol. 1985. PMID: 3161948
-
Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.J Clin Invest. 1980 Feb;65(2):290-7. doi: 10.1172/JCI109671. J Clin Invest. 1980. PMID: 6444305 Free PMC article.
-
The cleavage and inactivation of plasminogen activator inhibitor type 1 and alpha2-antiplasmin by reptilase, a thrombin-like venom enzyme.Blood Coagul Fibrinolysis. 2000 Mar;11(2):145-53. Blood Coagul Fibrinolysis. 2000. PMID: 10759007
-
Use of defibrinating agents ancrod and reptilase in the treatment of thromboembolism.Thromb Diath Haemorrh Suppl. 1973;56:239-51. Thromb Diath Haemorrh Suppl. 1973. PMID: 4617331 Review. No abstract available.
-
Fibrinolysis--a review.Ann Clin Lab Sci. 1984 Nov-Dec;14(6):443-9. Ann Clin Lab Sci. 1984. PMID: 6239587 Review.
Cited by
-
From Animal Poisons and Venoms to Medicines: Achievements, Challenges and Perspectives in Drug Discovery.Front Pharmacol. 2020 Jul 24;11:1132. doi: 10.3389/fphar.2020.01132. eCollection 2020. Front Pharmacol. 2020. PMID: 32848750 Free PMC article. Review.
-
Ancrod and fibrin formation: perspectives on mechanisms of action.Stroke. 2011 Nov;42(11):3277-80. doi: 10.1161/STROKEAHA.111.622753. Epub 2011 Aug 25. Stroke. 2011. PMID: 21868728 Free PMC article.
-
Postsurgical hemorrhage in dogs anticoagulated with ancrod (Arvin).Ann Surg. 1973 Dec;178(6):721-6. doi: 10.1097/00000658-197312000-00008. Ann Surg. 1973. PMID: 4759405 Free PMC article. No abstract available.
-
Purification, Characterization and Evaluation of the Antitumoral Activity of a Phospholipase A2 from the Snake Bothrops moojeni.Pharmaceuticals (Basel). 2022 Jun 7;15(6):724. doi: 10.3390/ph15060724. Pharmaceuticals (Basel). 2022. PMID: 35745643 Free PMC article.
-
Comparison of ancrod and heparin as anticoagulants following endarterectomy in the dog.Ann Surg. 1976 Aug;184(2):223-8. doi: 10.1097/00000658-197608000-00015. Ann Surg. 1976. PMID: 952568 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources